• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃癌中Lauren弥漫型和肠型亚型代谢差异的全基因组规模代谢模型分析

Genome-Scale Metabolic Model Analysis of Metabolic Differences between Lauren Diffuse and Intestinal Subtypes in Gastric Cancer.

作者信息

Nam Seungyoon, Lee Yongmin

机构信息

Department of Health Sciences and Technology, Gachon Advanced Institute for Health Sciences and Technology (GAIHST), Gachon University, Incheon 21999, Korea.

Department of Genome Medicine and Science, AI Convergence Center for Medical Science, Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon 21565, Korea.

出版信息

Cancers (Basel). 2022 May 9;14(9):2340. doi: 10.3390/cancers14092340.

DOI:10.3390/cancers14092340
PMID:35565469
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9104812/
Abstract

Gastric cancer (GC) is one of the most lethal cancers worldwide; it has a high mortality rate, particularly in East Asia. Recently, genetic events (e.g., mutations and copy number alterations) and molecular signaling associated with histologically different GC subtypes (diffuse and intestinal) have been elucidated. However, metabolic differences among the histological GC subtypes have not been studied systematically. In this study, we utilized transcriptome-based genome-scale metabolic models (GEMs) to identify differential metabolic pathways between Lauren diffuse and intestinal subtypes. We found that diverse metabolic pathways, including cholesterol homeostasis, xenobiotic metabolism, fatty acid metabolism, the MTORC1 pathway, and glycolysis, were dysregulated between the diffuse and intestinal subtypes. Our study provides an overview of the metabolic differences between the two subtypes, possibly leading to an understanding of metabolism in GC heterogeneity.

摘要

胃癌(GC)是全球最致命的癌症之一;其死亡率很高,尤其是在东亚地区。最近,与组织学上不同的GC亚型(弥漫型和肠型)相关的遗传事件(如突变和拷贝数改变)及分子信号传导已得到阐明。然而,组织学GC亚型之间的代谢差异尚未得到系统研究。在本研究中,我们利用基于转录组的基因组规模代谢模型(GEMs)来识别劳伦弥漫型和肠型亚型之间的差异代谢途径。我们发现,包括胆固醇稳态、异生物代谢、脂肪酸代谢、mTORC1途径和糖酵解在内的多种代谢途径在弥漫型和肠型亚型之间失调。我们的研究概述了这两种亚型之间的代谢差异,可能有助于理解GC异质性中的代谢情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ec/9104812/57ced6c56642/cancers-14-02340-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ec/9104812/cd9a2cef5a3c/cancers-14-02340-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ec/9104812/b4ba6131460d/cancers-14-02340-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ec/9104812/f42bf74d47cc/cancers-14-02340-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ec/9104812/c34de13589bb/cancers-14-02340-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ec/9104812/b0e82dbe7504/cancers-14-02340-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ec/9104812/57ced6c56642/cancers-14-02340-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ec/9104812/cd9a2cef5a3c/cancers-14-02340-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ec/9104812/b4ba6131460d/cancers-14-02340-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ec/9104812/f42bf74d47cc/cancers-14-02340-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ec/9104812/c34de13589bb/cancers-14-02340-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ec/9104812/b0e82dbe7504/cancers-14-02340-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ec/9104812/57ced6c56642/cancers-14-02340-g006.jpg

相似文献

1
Genome-Scale Metabolic Model Analysis of Metabolic Differences between Lauren Diffuse and Intestinal Subtypes in Gastric Cancer.胃癌中Lauren弥漫型和肠型亚型代谢差异的全基因组规模代谢模型分析
Cancers (Basel). 2022 May 9;14(9):2340. doi: 10.3390/cancers14092340.
2
Comparison of endoscopic gastritis based on Kyoto classification between diffuse and intestinal gastric cancer.基于京都分类法的弥漫性和肠型胃癌内镜下胃炎比较。
World J Gastrointest Endosc. 2021 May 16;13(5):125-136. doi: 10.4253/wjge.v13.i5.125.
3
Gastric cancer: new genetic developments.胃癌:新的遗传学进展
J Surg Oncol. 2005 Jun 1;90(3):114-33; discussion 133. doi: 10.1002/jso.20214.
4
Different effects of p53 protein overexpression on the survival of gastric cancer patients according to Lauren histologic classification: a retrospective study.根据 Lauren 组织学分型,p53 蛋白过表达对胃癌患者生存的不同影响:一项回顾性研究。
Gastric Cancer. 2021 Jul;24(4):844-857. doi: 10.1007/s10120-021-01163-y. Epub 2021 Feb 18.
5
Lauren classification and individualized chemotherapy in gastric cancer.胃癌的劳伦分类与个体化化疗
Oncol Lett. 2016 May;11(5):2959-2964. doi: 10.3892/ol.2016.4337. Epub 2016 Mar 16.
6
Integrated Analysis Identifies Molecular Signatures and Specific Prognostic Factors for Different Gastric Cancer Subtypes.综合分析确定不同胃癌亚型的分子特征和特定预后因素。
Transl Oncol. 2017 Feb;10(1):99-107. doi: 10.1016/j.tranon.2016.11.003. Epub 2016 Dec 22.
7
Occurrence of differing metabolic dysregulations, a glucose driven and another fatty acid centric in gastric cancer subtypes.在胃癌亚型中存在不同的代谢失调,一种是葡萄糖驱动的,另一种是脂肪酸为中心的。
Funct Integr Genomics. 2020 Nov;20(6):813-824. doi: 10.1007/s10142-020-00753-w. Epub 2020 Sep 19.
8
Proteomic Signatures of Diffuse and Intestinal Subtypes of Gastric Cancer.胃癌弥漫型和肠型亚型的蛋白质组学特征
Cancers (Basel). 2021 Nov 25;13(23):5930. doi: 10.3390/cancers13235930.
9
Identification of a molecular signature of prognostic subtypes in diffuse-type gastric cancer.弥漫型胃癌预后亚型的分子特征鉴定。
Gastric Cancer. 2020 May;23(3):473-482. doi: 10.1007/s10120-019-01029-4. Epub 2019 Nov 26.
10
Identification of oncogenic signaling pathways associated with the dimorphic metabolic dysregulations in gastric cancer subtypes.鉴定与胃癌亚型二相代谢失调相关的致癌信号通路。
Med Oncol. 2022 Jun 20;39(9):132. doi: 10.1007/s12032-022-01717-9.

引用本文的文献

1
1-Deoxynojirimycin containing Morus alba leaf-based food modulates the gut microbiome and expression of genes related to obesity.1-基于桑叶的含去氧野尻霉素食品调节肠道微生物组和与肥胖相关基因的表达。
BMC Vet Res. 2024 Apr 3;20(1):133. doi: 10.1186/s12917-024-03961-9.
2
The emerging role of glycolysis and immune evasion in gastric cancer.糖酵解与免疫逃逸在胃癌中的新作用
Cancer Cell Int. 2023 Dec 9;23(1):317. doi: 10.1186/s12935-023-03169-1.
3
Lipid metabolism characterization in gastric cancer identifies signatures to predict prognostic and therapeutic responses.

本文引用的文献

1
Genome Scale Modeling to Study the Metabolic Competition between Cells in the Tumor Microenvironment.用于研究肿瘤微环境中细胞间代谢竞争的基因组规模建模
Cancers (Basel). 2021 Sep 14;13(18):4609. doi: 10.3390/cancers13184609.
2
Guided extraction of genome-scale metabolic models for the integration and analysis of omics data.用于组学数据整合与分析的基因组规模代谢模型的引导式提取。
Comput Struct Biotechnol J. 2021 Jun 8;19:3521-3530. doi: 10.1016/j.csbj.2021.06.009. eCollection 2021.
3
Construction and Validation of a Novel Glycometabolism-Related Gene Signature Predicting Survival in Patients With Ovarian Cancer.
胃癌中的脂质代谢特征可识别预测预后和治疗反应的特征。
Front Genet. 2022 Nov 3;13:959170. doi: 10.3389/fgene.2022.959170. eCollection 2022.
一种预测卵巢癌患者生存的新型糖代谢相关基因特征的构建与验证
Front Genet. 2020 Nov 12;11:585259. doi: 10.3389/fgene.2020.585259. eCollection 2020.
4
Signal transduction pathway mutations in gastrointestinal (GI) cancers: a systematic review and meta-analysis.胃肠道(GI)癌症中的信号转导通路突变:系统评价和荟萃分析。
Sci Rep. 2020 Oct 30;10(1):18713. doi: 10.1038/s41598-020-73770-1.
5
The Role of Proteoglycans in Cancer Metastasis and Circulating Tumor Cell Analysis.蛋白聚糖在癌症转移和循环肿瘤细胞分析中的作用
Front Cell Dev Biol. 2020 Aug 26;8:749. doi: 10.3389/fcell.2020.00749. eCollection 2020.
6
The Pivotal Role of the Dysregulation of Cholesterol Homeostasis in Cancer: Implications for Therapeutic Targets.胆固醇稳态失调在癌症中的关键作用:对治疗靶点的启示
Cancers (Basel). 2020 May 29;12(6):1410. doi: 10.3390/cancers12061410.
7
Metabolic profiling reveals that salidroside antagonizes hypoxic injury via modulating energy and lipid metabolism in cardiomyocytes.代谢组学分析表明,红景天苷通过调节心肌细胞的能量和脂质代谢来拮抗低氧损伤。
Biomed Pharmacother. 2020 Feb;122:109700. doi: 10.1016/j.biopha.2019.109700. Epub 2019 Dec 30.
8
Mechanisms and regulation of cholesterol homeostasis.胆固醇稳态的机制和调节。
Nat Rev Mol Cell Biol. 2020 Apr;21(4):225-245. doi: 10.1038/s41580-019-0190-7. Epub 2019 Dec 17.
9
Reprogramming of fatty acid metabolism in cancer.癌症中脂肪酸代谢的重编程。
Br J Cancer. 2020 Jan;122(1):4-22. doi: 10.1038/s41416-019-0650-z. Epub 2019 Dec 10.
10
HMGCS2 Mediates Ketone Production and Regulates the Proliferation and Metastasis of Hepatocellular Carcinoma.HMGCS2介导酮体生成并调节肝细胞癌的增殖和转移。
Cancers (Basel). 2019 Nov 26;11(12):1876. doi: 10.3390/cancers11121876.